We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
+14.02%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$3.12B
AUM Growth
+$688M
Cap. Flow
+$367M
Cap. Flow %
11.77%
Top 10 Hldgs %
35.33%
Holding
664
New
163
Increased
269
Reduced
171
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 19.13%
2 Industrials 13.11%
3 Financials 10.41%
4 Healthcare 9.61%
5 Consumer Discretionary 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRMK.WS
626
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$121K ﹤0.01%
449,148
LMRK
627
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$118K ﹤0.01%
+11,000
New +$116K
SRTA
628
Strata Critical Medical Inc
SRTA
$440M
$111K ﹤0.01%
+10,000
New +$102K
JRO
629
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$97K ﹤0.01%
+11,221
New +$93.5K
ORGS
630
DELISTED
Orgenesis Inc. Common Stock
ORGS
$90K ﹤0.01%
2,000
PNNT
631
Pennant Park Investment Corp
PNNT
$221M
$76K ﹤0.01%
16,450
-550
-3% -$2.08K
SAN icon
632
Banco Santander
SAN
$200B
$74K ﹤0.01%
24,187
+1,430
+6% +$3.62K
LAB icon
633
Standard BioTools
LAB
$311M
$72K ﹤0.01%
12,000
NSL
634
DELISTED
NUVEEN SENIOR INCM FD
NSL
$60K ﹤0.01%
+11,570
New +$57.6K
LYG icon
635
Lloyds Banking Group
LYG
$87.2B
$32K ﹤0.01%
16,286
-22,275
-58% -$37.5K
PVLA
636
Palvella Therapeutics
PVLA
$2.05B
$26K ﹤0.01%
129
-2,250
-95% -$468K
CATX icon
637
Perspective Therapeutics
CATX
$327M
$18K ﹤0.01%
4,000
RMTI icon
638
Rockwell Medical
RMTI
$27.6M
$15K ﹤0.01%
136
-137
-50% -$15.3K
NAK
639
Northern Dynasty Minerals
NAK
$812M
$7K ﹤0.01%
20,954
BBEU icon
640
JPMorgan BetaBuilders Europe ETF
BBEU
$9.22B
-4,457
Closed -$204K
BOE icon
641
BlackRock Enhanced Global Dividend Trust
BOE
$666M
-13,014
Closed -$125K
VISN
642
Vistance Networks Inc
VISN
$2.67B
-25,000
Closed -$225K
DCO icon
643
Ducommun
DCO
$2.68B
-10,625
Closed -$350K
DXJ icon
644
WisdomTree Japan Hedged Equity Fund
DXJ
$7.12B
-4,716
Closed -$231K
EOG icon
645
EOG Resources
EOG
$74.4B
-20,161
Closed -$725K
FARO
646
DELISTED
Faro Technologies
FARO
-6,500
Closed -$396K
FTK icon
647
Flotek Industries
FTK
$856M
-1,667
Closed -$27K
GSK icon
648
GSK
GSK
$108B
-16,318
Closed -$768K
HRTX icon
649
Heron Therapeutics
HRTX
$92M
-35,600
Closed -$528K
IQDF icon
650
FlexShares International Quality Dividend Index Fund
IQDF
$1.13B
-49,406
Closed -$1.02M

Similar funds

Cerity Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Cerity Partners held 664 positions worth $3.12B, up 28% from $2.43B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Cerity Partners deployed $367M of net new capital in Q4 2020, opening 163 new positions and adding to 269 existing holdings. Its largest new stake was iShares Intermediate Government/Credit Bond ETF: 161,946 shares worth $19.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Illinois Tool Works, an estimated $21.9M trimmed.

  • Cerity Partners's largest Q4 2020 buy was iShares Intermediate Government/Credit Bond ETF: 161,946 shares worth $19.1M.
  • Cerity Partners added most to Golub Capital BDC in Q4 2020, an estimated $25.2M increase.
  • Cerity Partners's biggest Q4 2020 reduction was Illinois Tool Works, cutting an estimated $21.9M.
  • Cerity Partners fully exited NuVasive, Inc. in Q4 2020, selling an estimated $10.8M.
  • Cerity Partners's ten largest holdings make up 35% of its $3.12B portfolio in Q4 2020.
  • Cerity Partners opened 163 new positions and closed 24 in Q4 2020.
  • Cerity Partners's portfolio value rose 28% quarter-over-quarter to $3.12B.

Based on Cerity Partners's 13F filing for Q4 2020, filed 11 Feb 2021.